Patent US3500967A successfully refreshed from Google Patents.
Patent US4837014A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4837014A Expired / Lapsed US ⏱️ 0.0 years remaining

An improved method of treating sickle cell anemia

Assignee: Emory University
•
Filing: 1989-01-13
•
Granted: 1989-06-06
•
Expires: 2009-01-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract In accordance with the present invention, a method is provided that is effective in treating sickle cell anemia. The method comprises a method of treating a person with sickle cell disease comprising the step of injecting into the person with sickle cell disease a solution with an effective concentration of a surface active copolymer of the following formula: HO(C2H4O)b(C3H6O)a(C2H4O)bH wherein a is an integer such that the hydrophobe represented by (C3H6O) has a molecular weight of approximately 950 to 4000 and b is an integer such that the hydrophile portion represented by (C2H4O) constitutes approximately 50% to 90% by weight of the compound.

Inventors

  • 👤 Robert L. Hunter
  • 👤 Alexander Duncan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 22:55
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/43; A61K38/44; A61K38/446; A01; A01N; A01N1/00; A01N1/10; A01N1/12; A01N1/122; A01N1/126; A61K31/00; A61K31/74; A61K31/765; A61K38/164; A61K38/166; A61K38/46; A61K38/48; A61K38/49

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 113 words
A method of treating a person with sickle cell disease comprising the step of injecting into the person with sickle cell disease a solution with a fibrinolytic composition therein, the composition comprising an effective concentration of a fibrinolytic enzyme and an effective amount of a surface-active copolymer of the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 950 to 4000, and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes approximately 50% to 90% by weight of the compound.
Claim 2
Independent Claim 113 words
A method of treating a person with sickle cell disease comprising the step of injecting into the person with sickle cell disease a solution with a fibrinolytic composition therein, the composition comprising an effective concentration of a fibrinolytic enzyme and an effective amount of a surface-active copolymer of the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 950 to 4000, and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes approximately 50% to 90% by weight of the compound.
Claim 3
Dependent Claim 49 words
The method of claim 1 wherein said surface-active copolymer has the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein the molecular weight of the hydrophobe (C 3 H 6 O) Is approximately 1750 and the total molecular weight of the compound is approximately 8400.
Claim 4
Independent Claim 98 words
A method of treating a person with sickle cell disease comprising the step of injecting into the person with sickle cell disease a solution comprising an effective concentration of a surface-active copolymer of the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 950 to 4000, and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes approximately 50% to 90% by weight of the compound.
Claim 5
Independent Claim 98 words
A method of treating a person with sickle cell disease comprising the step of injecting into the person with sickle cell disease a solution comprising an effective concentration of a surface-active copolymer of the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein a is an integer such that the hydrophobe represented by (C 3 H 6 O) has a molecular weight of approximately 950 to 4000, and b is an integer such that the hydrophile portion represented by (C 2 H 4 O) constitutes approximately 50% to 90% by weight of the compound.
Claim 6
Dependent Claim 49 words
The method of claim 3 wherein said surface-active copolymer has the following formula: HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b H wherein the molecular weight of the hydrophobe (C 3 H 6 O) is approximately 1750 and the total molecular weight of the compound is approximately 8400.

References Cited (Backward Citations)

US3740421A Cited
US3450502A Cited
US3641240A Cited
US3577522A Cited
US3590125A Cited
US3980772A Cited
US3956259A Cited
US4073886A Cited
US4186253A Cited
US4609546A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-06-05 1992-12-05 1993-06-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-06-05 1996-12-05 1997-06-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-06-05 2000-12-05 2001-06-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag